Detalles de la búsqueda
1.
The Prognostic and therapeutic value and clinical implications of fibroblast activation protein-α as a novel biomarker in colorectal cancer.
Cell Commun Signal;
21(1): 139, 2023 06 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37316886
2.
Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide.
Cell Commun Signal;
21(1): 188, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37528446
3.
Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response.
Pharm Res;
39(2): 353-367, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35166995
4.
Retraction Note: Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response.
Pharm Res;
40(2): 615-616, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36477758
5.
Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor responses.
Life Sci;
309: 121008, 2022 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36179812
6.
Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells.
Int Immunopharmacol;
101(Pt A): 108288, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34710844
Resultados
1 -
6
de 6
1
Próxima >
>>